Lebende Larven von Lucilia sericata (1) – BioBag, BioMonde Freie Larven®, BioMonde® Freie Larven
Chronic or hard to heal wounds
Characteristics
| Start date | 01.06.2014 |
|---|---|
| Resolution | 20.11.2014 |
| INN | Lebende Larven von Lucilia sericata |
| Brand name | BioBag, BioMonde Freie Larven®, BioMonde® Freie Larven |
| Pharm. company | BioMonde GmbH |
| G-BA Procedure ID | D-115 |
| ATC code | D03AX32 Other cicatrizants (D03AX) |
| Therapeutic area | Other diseases |
| Reason for procedure | Initial assessment |
Studies and Results
Debridement of infected chronic or severe slow-healing wounds where surgical treatment using instruments is not desired
- As the necessary proof has not been provided, the additional benefit in relation to the appropriate comparator therapy is deemed not proven (Section 35a(1), fifth sentence, of Book V of the Social Code [SGB V]).
- Appropriate comparator therapy
- The appropriate comparator therapy for the debridement of infected chronic or severe slow-healing wounds is a debridement technique suitable for the individual patient, as chosen by the doctor.
- Criteria for selecting the debridement technique include, amongst other things, the type of wound, as well as its location and size.
Courtesy translation only, please refer to the German original.
Associated procedures
| Lebende Larven von Lucilia sericata (1) | BioBag, BioMonde Freie Larven® | BioMonde GmbH | Chronic or hard to heal wounds | 500,000–1,000,000 | 100% additional benefit not proven |
<< List of all resolutions